Escherichia coli carrying bla CTX-M genes have been spreading globally, but there are geographical variations in the type of bla CTX-M genes prevalent and there are scanty data from India. This study was conducted to determine the CTX-M type ESBLs in E. coli isolates obtained from clinical specimens from patients with extra-intestinal infections attending a tertiary care hospital in south India.
Extended-spectrum β-lactamases (ESBLs) are the most prevalent type of antimicrobial resistance mechanisms among Enterobacteriaceae such as Escherichia coli and Klebsiella pneumoniae 1 . There are over 200 enzymes characterized to be in the ESBL spectrum, which are encoded by plasmid or chromosomally carried genes 1 . Several studies indicate that CTX-M-type ESBLs are spreading globally and becoming dominant types in Enterobacteriaceae in many countries 2, 3 . However, the diversity of CTX-M types occurring in India is yet to be fully understood. There are only a few reports of molecular identification of β-lactamases. For example, a few studies indicated that CTX-M-15 could be the predominant ESBL in northern India 4, 5 . Report from south India 5,6 has indicated the prevalence of CTX-M-1-type gene in 58.3 per cent of Klebsiella spp. and in 36 per cent of E. coli. This study was undertaken to estimate the presence of CTX-M type ESBLs in E. coli isolated from samples of extra-intestinal infections in patients attending a tertiary care hospital in south India.
Material & Methods
Three hundred isolates of E. coli obtained from urine, wound swab, sputum, pus, endotracheal secretions, bronchoalveolar lavage, bile fluids and other fluids from sterile body sites such as pleural fluid, bile, peritoneal fluid and blood cultures were collected over two and a half years (2013) (2014) (2015) (2016) in the Microbiology department of The Madras Medical Mission, a tertiary care hospital in Chennai, India. Standard clinical microbiological procedures were used for the isolation of E. coli 7 and identification was done through VITEK II compact (BioMérieux, France). Antimicrobial susceptibility testing was done in Mueller-Hinton agar according to the current Clinical and Laboratory Standards Institute (CLSI) guidelines [8] [9] [10] [11] .
Phenotypic testing for ESBLs: ESBL phenotypic screening was performed for all the isolates by the double-disk diffusion test using ceftazidime (30 µg) and ceftazidime/clavulanic acid [8] [9] [10] [11] . E. coli ATCC 25922 and E. coli ATCC BAA-2326 were used as the negative and positive controls and the zone diameter interpreted as per the CLSI M-100 recommended guidelines [8] [9] [10] [11] . ESBL phenotypic confirmatory test was performed by the double-disk diffusion method using antibiotic disks containing a combination of cephalosporin plus clavulanic acid in combination with a corresponding cephalosporin disk alone [8] [9] [10] [11] .
Storage of isolates:
Isolates were transferred to semisolid agar and stored at −20°C. For long-term storage, cultures were suspended in Luria-Bertani (LB) broth (Himedia, India) with 30 per cent glycerol and stored at −80°C.
Molecular testing for CTX-M:
As per the antibiogram analyzed over 2013 to 2016 the rate of ESBL-positive organisms was 70-80 per cent among various isolates from The Madras Medical Mission. All isolates were subjected to (PCR) using four sets of primers and PCR conditions described earlier for CTX-M groups 12 .
Sequencing of β-lactamase gene from a typical strain:
To amplify the entire β-lactamase gene of Group I (CTX-M-15), the sequence from E. coli strain KS127 (accession number AB976567.1) was accessed from GenBank (https://www.ncbi.nlm.nih.gov/nuccore/ AB976567). Primer design was based on primer search using NCBI Primer BLAST (https://www.ncbi.nlm.nih. gov/tools/primer-blast/). The annealing temperature used for amplification was 55°C. An isolate of E. coli, IRU1638, recovered from a patient with urinary tract infection was used to sequence the β-lactamase gene. PCR products obtained at 56°C were sequenced by Eurofins, Bengaluru, and the sequence was subjected to nucleotide BLAST search.
Sequencing internal region of β-lactamase of a few
representative isolates: Ten representative isolates were selected based on source of isolation (7 urine, 2 blood and 1 bile fluid) and varying antibiogram for sequencing of internal region of bla
Results & Discussion
Of the 300 isolates tested, 238 (79.3%) were positive for Group I CTX-M-15 (Table I) , and of these, majority 174 (73.1%) were urine isolates. Group IV had eight isolates and Group II and III had only one isolate each. Seventeen isolates showed mixed reactions, nine being positive for both Groups I and II, four with both Groups I and III and three isolates with Groups I and IV (Table I) . Urine isolates accounted for 73 per cent of CTX-M Group I, while among CTX-M-negative isolates, urine accounted for 63 per cent (Table I ). In a study of 140 Enterobacteriaceae ESBL producers from eastern India 13 , the most common gene was bla TEM (96.42%) followed by bla CTX-M (75%) and bla SHV (17.85%). Another study from Central India 14 found that among the 526 urinary isolates of E. coli, the most common resistance gene detected was bla TEM (48.7%) followed by bla CTX-M (7.6%). Our study showed that 88 per cent of the E. coli isolated from extra-intestinal infections carried bla CTX-M (Table I) . This finding was similar to a study from Chennai Our study also demonstrated that bla CTX-M Group I was the dominant group among extra-intestinal E. coli isolates. A study from Korea 16 noted that of the 80 bla CTX-M carrying extra-intestinal E. coli studied, 36 carried bla CTX-M-15 (Group I), while 46 carried bla CTX-M-14 (Group IV). Predominance of Group IV over Group I has also been reported from China
17
. Among 201 E. coli isolates studied from Shandong Province in China, 116 (57.7%) carried bla CTX-M-14 (Group IV) and only 31 (15.4%) carried bla CTX-M-15 (Group I). In river water in India, bla CTX-M15 accounted for 46 per cent of isolates while 32 per cent isolates were positive for bla TEM 18 .
The antibiogram pattern of isolates positive and negative for bla CTX-M is indicated in Table II . CTX-M-positive isolates showed lesser sensitivity to clavulanic acid (7%) in comparison to sulbactam (62%) and tazobactam (55%). Majority (91%) of bla CTX-M -positive isolates showed meropenem sensitivity compared to those negative for this gene (72%).
The full-length bla CTX-M-15 was amplified and sequenced in one typical isolate and a 356 bp internal fragment was amplified and sequenced in 10 isolates. BLAST analysis showed that these sequences had 100 per cent similarity to bla CTX-M-15 from E. coli and Klebsiella spp. in GenBank. These data confirmed the results obtained with group-specific primers. To conclude, the most common type of ESBL in this small single-centre study was identified to be CTX-M-15. Cefoperazone-sulbactam may be a better choice than piperacillin-tazobactam in our setting. Further studies need to be done on a large number of isolates in different parts of the country.
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